02/01/2026
🇹🇩 Asistam in ultimii ani la o campanie extrem de agresiva, la nivel mondial, in legatura cu endometrioza pelvina si tratamentul sau - medicamentos/chirurgical.
Din pacate, uneori alte patologii pot trece nediagnosticate, asa cm este patologia oncologica.
Este biecunoscut faptul ca endometrioza pelvina (endometrioza ovariana) creste riscul de aparitie al cancerului ovarian. Mai exact, endometrioamele ovariene, cu evolutie indelungata, de dimensiuni crescute (peste 5 cm) prezinta risc de transformare maligna. De aceea recomandam efectuarea, in afara examenului RMN pelvin dedicat (insa si cu substanta de contrast), si a markerilor tumorali - Scor ROMA (CA-125) - nu ca diagnostic in endometrioza, si mai ales reprezinta un marker de agresivitate a bolii si a riscului de transformare maligna.
Am diagnosticat si tratat in cadrul centrului nostru (inclusiv paciente internationale), cel putin 20 de asemena cazuri in ultimii ani la paciente tinere, cu varste intre 30 si 45 de ani. Acest risc de transformare maligna a endometrioamelor este si mai crescut la pacientele care nu au avut sarcini sau care au efectuat multiple tratamente de obtinere a acesteia (stimulare ovariana - proceduri ART/IVF).
Scriu acest lucru prin prisma unui caz dramatic operat recent in cadrul centrului nostru. Pacienta, cunoscuta cu endometrioza - endometrioame ovariene voluminoase, era monitorizata la 6-12 luni de cel putin 3 ani.
Din pacate, cand a ajuns la noi, suspiciunea de malignitate era foarte mare si am intervenit oarecum de urgenta in acest caz. Boala era destul de avansata, insa am reusit, impreuna cu echipa mea, sa efectuam interventia radicala, cu viza oncologica.
De aceea, recomandam atat colegilor, cat si pacientelor, sa nu ezite sa efectueze interventia chirurgicala (care de cele mai multe ori nu este una complexa), atunci cand exista endometrioame ovariene voluminoase (simptomatice sau nu), mai ales cand sunt asociate cu alti factori de risc ai cancerului ovarian.
De aceea cred ca centrele si medicii specializati in diagnosticul si tratamentul endometriozei nu trebuie sa se limiteze doar la patologia benigna ginecologica, ci trebuie sa aiba experienta si in chirurgia oncologica de anvergura.
🇬🇧 In recent years, we have witnessed an extremely aggressive campaign, worldwide, regarding pelvic endometriosis and its treatment - medical/surgical.
Unfortunately, sometimes other pathologies can go undiagnosed, such as oncological pathology.
It is well known that pelvic endometriosis (ovarian endometriosis) increases the risk of ovarian cancer. More precisely, ovarian endometriomas, known for many years, of increased size (over 5 cm) present a risk of malignant transformation. Therefore, we recommend performing, in addition to the dedicated pelvic MRI examination (but also with i.v. contrast), also tumor markers - ROMA Score (CA-125).
We have diagnosed and treated at our center (including international patients), at least 20 such cases in recent years in young patients, aged between 30 and 45 years. This risk of malignant transformation of endometriomas is even higher in patients who have not had a pregnancy or who have undergone multiple treatments to obtain it (ovarian stimulation - ART/IVF procedures).
I am writing this in light of a dramatic case recently operated on in our center. The patient, known to have endometriosis - voluminous ovarian endometriomas, was monitored every 6-12 months for at least 3 years.
Unfortunately, when she arrived at our office, the suspicion of malignancy was very high and we intervened somewhat urgently in this case. The disease was quite advanced, but we managed to perform the radical surgery, with an oncological aim.
Therefore, we recommend both colleagues and patients not to hesitate to perform the surgical intervention (which is most often not a complex one), when there are voluminous ovarian endometriomas (symptomatic or not), especially when they are associated with other risk factors for ovarian cancer.
That is why I believe that centers and doctors specializing in the diagnosis and treatment of endometriosis should not be limited to benign gynecological pathology, but should also have experience in large-scale oncological surgery.